SomantiX BV Information

SomantiX B.V. is a Dutch biotech company focusing on the identification and development of new angiogenesis inhibitors for the treatment of solid cancers through targeting of tumor blood vessels. Somantix’ screening platform in combination with the binder generation technologies allows validation of new therapeutic targets and development of new cancer medicines.

Website	http://www.somantix.com
Revenue	$1 million
Employees	1 (1 on RocketReach)
Founded	2008
Address	Padualaan 8, Kruyt Gebouw rm O.807, Utrecht, Utrecht 3584 CH, NL
Phone	+31 30 229 6092
Technologies	JavaScript , HTML , Google Analytics +8 more (view full list)
Industry	Biotechnology, Biotechnology Research, Pharmaceuticals, Other Healthcare, Healthcare
Keywords	Cancer Treatment, Biotech, Drug Discovery, Pharmaceutical, Oncology, Solid Tumors, Therapeutic Antibodies, Anti-Cancer Drugs, Clinical Trials, New Drug Development, Biotechnology, Pharmaceutical Research, Drug Development, Cancer Research, Molecular Medicine, Precision Medicine, Target Identification, Therapeutic Development
Competitors	Exact Sciences, Foundation Medicine, Guardant Health, Freenome, NantHealth, GRAIL, Thermo Fisher Scientific, carisls, NeoGenomics Laboratories, Myriad Genetics +46 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies